A majority of patients with breast cancer have hormone receptor-positive tumors; overexpression of estrogen receptors (ER) and/or progesterone receptors (PR) is observed in up to 77% of patients diagnosed with breast cancer [18]. This evidence concerns the gene NR4A1 and breast cancer.